CLINICAL_TRIALS
withdrawal
· 2012-04-16
Clinical Trial Update: Azithromycin in Control of Trachoma II [Phase 4]
Summary
A Phase 4 trial of azithromycin for the control of trachoma was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Trachoma | Phase 4 | Status: WITHDRAWN